The HIV epidemic in Indonesia is among the fastest growing in Asia, and limited funding is available for HIV/AIDS control.
The HIV epidemic in Indonesia is among the fastest growing in Asia, and limited funding is available for HIV/AIDS control. The epidemic is concentrated among injecting drug users (IDUs) and their sexual partners in most parts of the country, but generalised in some other parts.
This raises a number of important policy questions, about the adequacy of the level of available funding, the appropriateness of its use, and its financial sustainability. This paper puts these questions in context of the present Indonesian health system.
